Report ID: GIR2112240517 | Category: Pharma & Healthcare | Pages: 92 | Format: PDF | Published Date: October 17,2022
1 Market Overview 1.1 Flu Vaccine Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Flu Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028 1.2.2 Trivalent Influenza Vaccine 1.2.3 Quadrivalent Influenza Vaccine 1.3 Market Analysis by Application 1.3.1 Overview: Global Flu Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028 1.3.2 For Children (6 months to 3 years) 1.3.3 For Adults and Children over 3 years 1.4 Global Flu Vaccine Market Size & Forecast 1.4.1 Global Flu Vaccine Sales in Value (2017 & 2021 & 2028) 1.4.2 Global Flu Vaccine Sales in Volume (2017-2028) 1.4.3 Global Flu Vaccine Price (2017-2028) 1.5 Global Flu Vaccine Production Capacity Analysis 1.5.1 Global Flu Vaccine Total Production Capacity (2017-2028) 1.5.2 Global Flu Vaccine Production Capacity by Geographic Region 1.6 Market Drivers, Restraints and Trends 1.6.1 Flu Vaccine Market Drivers 1.6.2 Flu Vaccine Market Restraints 1.6.3 Flu Vaccine Trends Analysis 2 Manufacturers Profiles 2.1 Sanofi Pasteur 2.1.1 Sanofi Pasteur Details 2.1.2 Sanofi Pasteur Major Business 2.1.3 Sanofi Pasteur Flu Vaccine Product and Services 2.1.4 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.2 CSL 2.2.1 CSL Details 2.2.2 CSL Major Business 2.2.3 CSL Flu Vaccine Product and Services 2.2.4 CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.3 GSK 2.3.1 GSK Details 2.3.2 GSK Major Business 2.3.3 GSK Flu Vaccine Product and Services 2.3.4 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.4 Mylan 2.4.1 Mylan Details 2.4.2 Mylan Major Business 2.4.3 Mylan Flu Vaccine Product and Services 2.4.4 Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.5 Hulan Bio 2.5.1 Hulan Bio Details 2.5.2 Hulan Bio Major Business 2.5.3 Hulan Bio Flu Vaccine Product and Services 2.5.4 Hulan Bio Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.6 AstraZeneca 2.6.1 AstraZeneca Details 2.6.2 AstraZeneca Major Business 2.6.3 AstraZeneca Flu Vaccine Product and Services 2.6.4 AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.7 CCBIO 2.7.1 CCBIO Details 2.7.2 CCBIO Major Business 2.7.3 CCBIO Flu Vaccine Product and Services 2.7.4 CCBIO Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 3 Flu Vaccine Breakdown Data by Manufacturer 3.1 Global Flu Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022) 3.2 Global Flu Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) 3.3 Key Manufacturer Market Position in Flu Vaccine 3.4 Market Concentration Rate 3.4.1 Top 3 Flu Vaccine Manufacturer Market Share in 2021 3.4.2 Top 6 Flu Vaccine Manufacturer Market Share in 2021 3.5 Global Flu Vaccine Production Capacity by Company: 2021 VS 2022 3.6 Manufacturer by Geography: Head Office and Flu Vaccine Production Site 3.7 New Entrant and Capacity Expansion Plans 3.8 Mergers & Acquisitions 4 Market Analysis by Region 4.1 Global Flu Vaccine Market Size by Region 4.1.1 Global Flu Vaccine Sales in Volume by Region (2017-2028) 4.1.2 Global Flu Vaccine Revenue by Region (2017-2028) 4.2 North America Flu Vaccine Revenue (2017-2028) 4.3 Europe Flu Vaccine Revenue (2017-2028) 4.4 Asia-Pacific Flu Vaccine Revenue (2017-2028) 4.5 South America Flu Vaccine Revenue (2017-2028) 4.6 Middle East and Africa Flu Vaccine Revenue (2017-2028) 5 Market Segment by Type 5.1 Global Flu Vaccine Sales in Volume by Type (2017-2028) 5.2 Global Flu Vaccine Revenue by Type (2017-2028) 5.3 Global Flu Vaccine Price by Type (2017-2028) 6 Market Segment by Application 6.1 Global Flu Vaccine Sales in Volume by Application (2017-2028) 6.2 Global Flu Vaccine Revenue by Application (2017-2028) 6.3 Global Flu Vaccine Price by Application (2017-2028) 7 North America by Country, by Type, and by Application 7.1 North America Flu Vaccine Sales by Type (2017-2028) 7.2 North America Flu Vaccine Sales by Application (2017-2028) 7.3 North America Flu Vaccine Market Size by Country 7.3.1 North America Flu Vaccine Sales in Volume by Country (2017-2028) 7.3.2 North America Flu Vaccine Revenue by Country (2017-2028) 7.3.3 United States Market Size and Forecast (2017-2028) 7.3.4 Canada Market Size and Forecast (2017-2028) 7.3.5 Mexico Market Size and Forecast (2017-2028) 8 Europe by Country, by Type, and by Application 8.1 Europe Flu Vaccine Sales by Type (2017-2028) 8.2 Europe Flu Vaccine Sales by Application (2017-2028) 8.3 Europe Flu Vaccine Market Size by Country 8.3.1 Europe Flu Vaccine Sales in Volume by Country (2017-2028) 8.3.2 Europe Flu Vaccine Revenue by Country (2017-2028) 8.3.3 Germany Market Size and Forecast (2017-2028) 8.3.4 France Market Size and Forecast (2017-2028) 8.3.5 United Kingdom Market Size and Forecast (2017-2028) 8.3.6 Russia Market Size and Forecast (2017-2028) 8.3.7 Italy Market Size and Forecast (2017-2028) 9 Asia-Pacific by Region, by Type, and by Application 9.1 Asia-Pacific Flu Vaccine Sales by Type (2017-2028) 9.2 Asia-Pacific Flu Vaccine Sales by Application (2017-2028) 9.3 Asia-Pacific Flu Vaccine Market Size by Region 9.3.1 Asia-Pacific Flu Vaccine Sales in Volume by Region (2017-2028) 9.3.2 Asia-Pacific Flu Vaccine Revenue by Region (2017-2028) 9.3.3 China Market Size and Forecast (2017-2028) 9.3.4 Japan Market Size and Forecast (2017-2028) 9.3.5 Korea Market Size and Forecast (2017-2028) 9.3.6 India Market Size and Forecast (2017-2028) 9.3.7 Southeast Asia Market Size and Forecast (2017-2028) 9.3.8 Australia Market Size and Forecast (2017-2028) 10 South America by Region, by Type, and by Application 10.1 South America Flu Vaccine Sales by Type (2017-2028) 10.2 South America Flu Vaccine Sales by Application (2017-2028) 10.3 South America Flu Vaccine Market Size by Country 10.3.1 South America Flu Vaccine Sales in Volume by Country (2017-2028) 10.3.2 South America Flu Vaccine Revenue by Country (2017-2028) 10.3.3 Brazil Market Size and Forecast (2017-2028) 10.3.4 Argentina Market Size and Forecast (2017-2028) 11 Middle East & Africa by Country, by Type, and by Application 11.1 Middle East & Africa Flu Vaccine Sales by Type (2017-2028) 11.2 Middle East & Africa Flu Vaccine Sales by Application (2017-2028) 11.3 Middle East & Africa Flu Vaccine Market Size by Country 11.3.1 Middle East & Africa Flu Vaccine Sales in Volume by Country (2017-2028) 11.3.2 Middle East & Africa Flu Vaccine Revenue by Country (2017-2028) 11.3.3 Turkey Market Size and Forecast (2017-2028) 11.3.4 Egypt Market Size and Forecast (2017-2028) 11.3.5 Saudi Arabia Market Size and Forecast (2017-2028) 11.3.6 South Africa Market Size and Forecast (2017-2028) 12 Raw Material and Industry Chain 12.1 Raw Material of Flu Vaccine and Key Manufacturers 12.2 Manufacturing Costs Percentage of Flu Vaccine 12.3 Flu Vaccine Production Process 12.4 Flu Vaccine Industrial Chain 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Flu Vaccine Typical Distributors 13.3 Flu Vaccine Typical Customers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Research Process and Data Source 15.3 Disclaimer
It contains all the geographic trends, and market analysis for global market